Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMobius Investm. Regulatory News (MMIT)

Share Price Information for Mobius Investm. (MMIT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 131.00
Bid: 129.50
Ask: 131.00
Change: 1.00 (0.77%)
Spread: 1.50 (1.158%)
Open: 130.50
High: 136.00
Low: 130.00
Prev. Close: 130.00
MMIT Live PriceLast checked at -
Mobius Investment is an Investment Trust

To achieve long-term capital growth and income returns predominantly through investment in a diversified portfolio of companies exposed directly or indirectly to emerging or frontier markets.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Investment Manager Update

10 Nov 2023 11:16

RNS Number : 1072T
Mobius Investment Trust PLC
10 November 2023

10 November 2023

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE MARKET ABUSE REGULATION EU 596/2014 AS IT FORMS PART OF UK DOMESTIC LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018.

Mobius Investment Trust plc

(the "Company" or "MMIT")

Investment Manager Update

Mobius Investment Trust plc is pleased to announce its 5-Year anniversary with significant outperformance against the benchmark and its peer group in the period since the Company's IPO. This milestone underscores the Company's commitment to delivering sustainable outsized investment returns.

Founding Partner Dr Mark Mobius has notified the Company and the Company's Investment Manager, Mobius Capital Partners LLP ("MCP"), of his intention to step back from the partnership in the coming months, leaving a legacy of excellence and devotion to MCP and the Company. His contributions have been pivotal to the Company's success, and his approach of emerging market investing since the 1980s remains embedded in MCP's investment philosophy.

MMIT will continue to be managed by MCP, which is led by Carlos Hardenberg, supported by an experienced team of emerging markets specialists. Carlos has been investing in emerging markets and working closely with Dr Mobius for over 23 years. He successfully managed country, regional and global emerging and frontier market portfolios including the largest London listed emerging markets trust generating significant outperformance over the entire period.

Founding Partner Carlos Hardenberg said: "Our journey over the past five years has been marked by progress, and we are genuinely grateful for the results we have achieved. We would like to extend our heartfelt gratitude to Mark for his exceptional contributions to emerging market investing over his long career and more recently to MCP and MMIT over the last five years. Mark's dedication has been instrumental to our success. As we look forward to the future, I intend to promote our most talented employees to the role of partners. This is to acknowledge their strong performance and commitment to MCP."

Dr Mobius expressed his sentiments, commenting: "I am proud of the investment team's strong performance during the last five years which proves that a concentrated and differentiated portfolio of high-quality stocks can generate exceptional returns. As a shareholder of the MMIT, I will be following the Company's progress closely and will continue to be available to the team and the Board."

Speaking on behalf of the Board, Maria Luisa Cicognani, Chairman of MMIT, said: "Mark and Carlos have been instrumental to MMIT's success and outperformance since our IPO, and with Mark now intending to leave the partnership, we would like to express our immense gratitude to him for his advice and expertise over the years. We look forward to continuing to work with Mark, drawing on his support and vast knowledge of emerging markets, as MCP progresses with a strong and committed team led by Carlos which we are confident will continue to deliver outstanding results for our shareholders."

For further information please contact:

Mobius Capital Partners LLP

Anna von Hahn

Camarco

Eddie Livingstone Learmonth

Tel: +44 (0) 203 829 8500

Mob: +44 (0) 7852 882 770

Email: anna@mobiuscapitalpartners.com

Tel: +44 (0) 790 012 1128

Email: mobius@camarco.co.uk

-ENDS-

Frostrow Capital LLP

Company Secretary

Tel: 020 3170 8732

Neither the contents of the Company's website nor the contents of any website accessible from hyperlinks on the Company's website (or any other website) is incorporated into, or forms part of, this announcement.

LEI: 21380033EKFQS15X1W22

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
MSCFBLFFXFLFFBX
Date   Source Headline
6th Apr 20236:01 pmRNSIssue of Equity
6th Apr 20232:00 pmRNSNet Asset Value(s)
5th Apr 202311:48 amRNSNet Asset Value(s)
4th Apr 20233:54 pmRNSReplacement: Issue of Equity
4th Apr 20233:36 pmRNSIssue of Equity
4th Apr 202312:39 pmRNSNet Asset Value(s)
3rd Apr 20232:12 pmRNSNet Asset Value(s)
3rd Apr 202310:58 amRNSTotal Voting Rights
31st Mar 202312:11 pmRNSNet Asset Value(s)
30th Mar 20231:55 pmRNSNet Asset Value(s)
29th Mar 202312:18 pmRNSNet Asset Value(s)
29th Mar 20237:00 amRNSBlock listing Interim Review
28th Mar 202312:45 pmRNSNet Asset Value(s)
27th Mar 202311:57 amRNSNet Asset Value(s)
24th Mar 202312:34 pmRNSNet Asset Value(s)
23rd Mar 20235:01 pmRNSIssue of Equity
23rd Mar 20231:03 pmRNSNet Asset Value(s)
22nd Mar 20231:50 pmRNSNet Asset Value(s)
21st Mar 20231:17 pmRNSMonthly Fact Sheet as at 28 February 2023
21st Mar 202310:28 amRNSNet Asset Value(s)
20th Mar 20236:03 pmRNSHolding(s) in Company
20th Mar 202312:38 pmRNSNet Asset Value(s)
17th Mar 202311:15 amRNSNet Asset Value(s)
16th Mar 202311:48 amRNSNet Asset Value(s)
15th Mar 202312:52 pmRNSNet Asset Value(s)
14th Mar 202311:12 amRNSNet Asset Value(s)
13th Mar 202311:45 amRNSNet Asset Value(s)
10th Mar 20231:39 pmRNSNet Asset Value(s)
9th Mar 20231:44 pmRNSNet Asset Value(s)
8th Mar 20231:06 pmRNSNet Asset Value(s)
7th Mar 20231:18 pmRNSNet Asset Value(s)
6th Mar 20231:03 pmRNSNet Asset Value(s)
3rd Mar 202312:16 pmRNSNet Asset Value(s)
2nd Mar 202312:39 pmRNSNet Asset Value(s)
1st Mar 202311:37 amRNSNet Asset Value(s)
1st Mar 202310:50 amRNSTotal Voting Rights
1st Mar 202310:39 amRNSHolding(s) in Company
28th Feb 20233:25 pmRNSAnnual Financial Report
28th Feb 202310:53 amRNSNet Asset Value(s)
27th Feb 202311:33 amRNSNet Asset Value(s)
24th Feb 20231:39 pmRNSNet Asset Value(s)
23rd Feb 20231:47 pmRNSNet Asset Value(s)
22nd Feb 202311:35 amRNSMonthly Fact Sheet as at 31 January 2023
22nd Feb 202311:16 amRNSNet Asset Value(s)
21st Feb 202311:58 amRNSNet Asset Value(s)
20th Feb 202311:32 amRNSNet Asset Value(s)
17th Feb 202312:37 pmRNSNet Asset Value(s)
17th Feb 202312:03 pmRNSHolding(s) in Company
16th Feb 202312:13 pmRNSNet Asset Value(s)
15th Feb 202311:48 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.